Biotechnology Value Fund L P's Form 4 filing
ESSA Pharma Inc. (EPIX) · filed Aug 7, 2025
- Accession no.
- 0000921895-25-002133
- Filed
- Aug 7, 2025, 4:36 PM ET
- Trade date
- Aug 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $292.95. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | 10% Owner |
| BVF Partners L PCIK 0001055947 | 10% Owner |
| BVF IncCIK 0001056807 | 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Other: See Explanation of Responses |
| Lampert Mark NCIK 0001233840 | 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | 10% Owner |
| BVF II GP LLCCIK 0001803806 | Other: See Explanation of Responses |
| BVF GP Holdings LLCCIK 0001803809 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseAcquired | +1,481,634 | $0.0001 | +$148.16 | 6,194,224 | Direct | |
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseAcquired | +1,235,030 | $0.0001 | +$123.5 | 4,726,809 | Direct | |
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseAcquired | +203,336 | $0.0001 | +$20.33 | 560,808 | Direct | |
| Aug 5, 2025 | Common Stock | SSaleDisposed | −79 | $1.88 | −$148.35 | 6,194,145 | Direct | |
| Aug 5, 2025 | Common Stock | SSaleDisposed | −66 | $1.88 | −$123.94 | 4,726,743 | Direct | |
| Aug 5, 2025 | Common Stock | SSaleDisposed | −11 | $1.88 | −$20.66 | 560,797 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseDisposed | −1,481,634 | $0.00 | $0 | 0 | Direct | |
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseDisposed | −1,235,030 | $0.00 | $0 | 0 | Direct | |
| Aug 5, 2025 | Common Stock | XIn-the-money exerciseDisposed | −203,336 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.